A Real-World Study of EkoSonic Endovascular System in Chinese Populations With Acute Pulmonary Embolism

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBoston Scientific Corporation

About this trial

This study to collect the real-world clinical outcome data of EkoSonicTM Endovascular System in Chinese patients with acute pulmonary embolism during practical clinical care.

Eligibility criteria

Qualifiers

The patients with acute symptomatic pulmonary embolism (Symptomatic duration < 14 days).

The right ventricle diameter to left ventricle diameter of end-diastolic dimension ratio ≥1 measured by echocardiographic image

Investigator has selected the EkoSonicTM Endovascular System with r-tPA to treat patient.

Disqualifiers

The patients with acute symptomatic pulmonary embolism (Symptomatic duration < 14 days).

The right ventricle diameter to left ventricle diameter of end-diastolic dimension ratio ≥1 measured by echocardiographic image

Investigator has selected the EkoSonicTM Endovascular System with r-tPA to treat patient.

Trial design

Treatments tested in this trial

  • EkoSonicTM Endovascular System

Treatment groups

30 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators